Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T19:57:49.751Z.
Calculation as of: 2026-10-06T19:57:49.751Z.
Quote observation: 2026-10-06T19:55:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d441fe8f086afba93fb8397567d44bfe794a39cd606e17fb54204e4f45075d8b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$29.60M
EV/Sales Ratio
65.47x
TTM Avg
29.75x
3Y Avg
29.75x
5Y Avg
29.75x
Market Cap
$29.67M
EV/Sales Ratio
187.72x
TTM Avg
271.96x
3Y Avg
271.96x
5Y Avg
271.96x
Market Cap
$29.89M
EV/Sales Ratio
N/A
TTM Avg
70.91x
3Y Avg
45.25x
5Y Avg
208.18x
Market Cap
$28.59M
EV/Sales Ratio
19.87x
TTM Avg
66.22x
3Y Avg
47.59x
5Y Avg
61.65x
Market Cap
$30.43M
EV/Sales Ratio
0.49x
TTM Avg
0.48x
3Y Avg
0.60x
5Y Avg
0.58x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $29.74M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.32M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | 65.47x | 29.75x | 29.75x | 29.75x |
| GridAI Technologies Corp. (GRDX)vs › | $29.67M | 187.72x | 271.96x | 271.96x | 271.96x |
| BeyondSpring Inc. (BYSI)vs › | $29.89M | N/A | 70.91x | 45.25x | 208.18x |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.86M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $28.59M | 19.87x | 66.22x | 47.59x | 61.65x |
| SCYNEXIS, Inc. (SCYX)vs › | $30.31M | 1.13x | 4.69x | 4.99x | 8.32x |
| Rockwell Medical, Inc. (RMTI)vs › | $30.43M | 0.49x | 0.48x | 0.60x | 0.58x |
| CervoMed Inc. (CRVO)vs › | $30.55M | 25.08x | 97.17x | 97.17x | 97.17x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
